As of Mar 16
| +1.69 / +0.97%|
The 26 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 195.00, with a high estimate of 212.00 and a low estimate of 103.00. The median estimate represents a +11.01% increase from the last price of 175.66.
The current consensus among 29 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.